chrisvoncsefalvay/vaers-outcomes huggingface dataset:
experienced same thing; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (experienced same thing) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (experienced same thing). At the time of the report, VACCINATION COMPLICATION (experienced same thing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment information were given.   This case was linked to MOD21-167887 (E2B Linked Report). This case was linked to MOD-2021-400476 (Patient Link).; Sender's Comments:  MOD21-167887:
This case was reported by a other health professional via call center representative and described the occurrence of tingling tongue in a 68-year-old female patient who received SHINGRIX for prophylaxis. On 8th October 2018, the patient received the 1st dose of SHINGRIX. In October 2018, less than a day after receiving SHINGRIX, the patient experienced tingling tongue and numbness of tongue. On an unknown date, the outcome of the tingling tongue and numbness of tongue were not recovered/not resolved. It was unknown if the reporter considered the tingling tongue and numbness of tongue to be related to SHINGRIX. Additional details were provided as follows: The patient experienced tingling and numbness on the tip of the tongue since vaccination. The reporter did not give consent to follow up.
Pain, increased vol, redness, left upper arm. Keflex 250/5; 3/4 tsp PO qid x 2 days.
Tingling sensation on the left leg/ Tingling sensation on the right leg; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation on the left leg/ Tingling sensation on the right leg) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced PARAESTHESIA (Tingling sensation on the left leg/ Tingling sensation on the right leg). At the time of the report, PARAESTHESIA (Tingling sensation on the left leg/ Tingling sensation on the right leg) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
LITTLE, ITCHY PIMPLE TYPE BUMPS ON ARMS AND LEGS. RECEIVED A CORTISOL SHOT THE NEXT DAY.  TOOK ANOTHER 10 DAYS OR SO AFTER THAT FOR IT TO CLEAR UP.
The pt experienced redness and induration that measured 10 x 5cm on left thigh.
Information has been received from a registered nurse concerning a 9 week old female with no pertinent medical history or drug allergies who on 04-DEC-2007 and 05-FEB-2008 was vaccinated PO with her first and second doses of ROTATEQ (lot# 657673/0904U, lot# 659772/1636U).  There was no concomitant medication.  On approximately 11-DEC-2007 1 week after the first dose, the patient experienced diarrhea.  In December 2007, the patient's stool sample was positive for heme.  The patient was treated with electrolyte oral solution (PEDIALYTE).  The diarrhea continued and the infant was seen in an emergency room while the family was out of town on vacation.  No treatment was required in the emergency room.  On 07-JAN-2008 the infant was examined in the physician's office and a stool culture at the time was negative for heme, rotavirus and other pathogens.  The infant was then switched to a soy-based formula.  On 11-FEB-2008 the patient experienced profuse diarrhea.  The patient's mother contacted the physician's office by phone and supportive corrective fluids were recommended.  The patient's profuse diarrhea persisted.  There was no product quality complaint.  Upon internal review, heme-positive stool was determined to be an other important medical event.  Additional information has been requested.
Information has been received from a nurse concerning a female patient (age unknown) who on 24-OCT-2006 was vaccinated with a dose of Pneumovax 23 (Lot# 651399/0486F) and a dose of influenza virus vaccine (unspecified) in the other arm.  Subsequently the patient experienced redness, swelling and warm to touch at the injection site.  The patient sought unspecified medical attention.  The patient was treated with TYLENOL and BENADRYL.  The patient's injection site redness, swelling and warmth resolved approximately 24 hours later.  Additional information has been requested.
Warmth, swelling, redness, and pain at injection site about 5 x 5 inches.
3/21/21 - SVT event with easy exercise (2 weeks afer first vaccine) 3/23/21 - worst SVT event of life with intense exercise.  stopped exercising 4/12/21 - PVC 4 a minute never had them before.  irregular rythm.  feeling heart irritation (2 weeks after second dose) 4/25/21 - continues heart inflamation issues pvc's, rythm issues, chest tighteness, complete uncomfortableness 5/14/21 - after 3 weeks of absolute hell worst feeling of my life with my heart inflamation/irritation.  test not showing anything I started 600mg of Ibuprofen 3 times a day. 5/18/21 - Cardiac MRI but most irritation was going away after ibuprophen 5/25/21 - EP study and SVT ablation.  most issue had subsided before the proceedure from ibuprophen 6/5/21 - inflamation symptoms returned.  possible due to proceedure 6/9/21 - 600mb ibuprohen 3x a day started again.  conidtion starting to improve again  I was running 40 miles a week for over 4 years with no issues.  This all blew up shortly after starting vaccination and has been the most horrible experience of my life by far!
Bruising started at injection site and has expanded down the right arm up to the forearm through the time period of 3 days. and is associated with severe pain
Following pt 1st vax experienced low grade fever, pain, joint stiffness, dizziness, & nausea; vaccinated w/2nd dose of vax & again experienced similar sx; No furher details were provided;
Head to toe rash, respiratory distress, elevated temperature, (102 and higher), tachycardia.  Treatment required three trips to the emergency room where patient was given intravenous Benadryl, a selection of steroids, oxygen, antipyretics and supportive care.  4/3/09 MR received for DOS 3/12-15/2009 with D/C DX: Anaphylaxis, likely 2' to influenza and pneumococcal vaccines.  Recurrent wheezing and SOB x 48 hrs. Pt initially presented to ER 3/10/09 with throat swelling and hives. Tx and d/c. Returned with same sx 3/11/09 and tx and d/c. Returned 3/12/09 with recurring sx.  Noted to be acidotic, tachycardic with low Phosphorus and elevated WBCs. Admitted for IV steroids with resolution of hives, rash, SOB, cough, wheezing and throat swelling.
Initial unsolicited case received from a physician on 19 Dec 2016. This case involves a male patient (age not reported) who was vaccinated with a dose of ADACEL (Batch number: U5489AA, Expiry date, dose, route and site of administration was not reported) on 01 Dec 2016. The patient illness at the time of vaccination, preexisting physician diagnosed allergies, birth defects, medical conditions and any other vaccinations within four weeks of vaccinations was not reported. The patient concomitant medications were not reported. On an unknown date, after the vaccination (reported as of today 19 Dec 2016) the patient had right arm pain and due to pain he is not able to abduct right arm and it was reported as the patient will be coming to see the physician on 20 Dec 2016, for evaluation and treatment as needed. The patient lab tests and corrective treatment was not reported. The outcome of the events was unknown. List of documents held by sender: none.
Erythematous around injection site, injection site swelling and pain, painful, pectoral muscles, painful axillary lymph node, painful arm, pruritic injection site
When my son first woke up on the morning of 1/29/2022, he complained that he was seeing tiny white spots in his entire field of vision in both eyes. He subsequently said that he saw them everywhere, every day, and all day long. We saw his pediatrician on 1/31/2022. She suggested that I have him seen by an optometrist, so I took him to an optometrist later that same week. The optometrist dilated my son's pupils and did a thorough examination. The optometrist could find no abnormalities, but he suggested that my son could have snow vision syndrome, but he would need to be examined by an ophthalmologist for that to be ascertained. After my son got his second vaccine, he complained that his vision had worsened, so I took him to a pediatric optometrist. The pediatric optometrist dilated his pupils and examined his eyes. Like the previous optometrist, he could find no structural abnormalities and suggested that he could have snow vision syndrome. The pediatric optometrist is currently trying to arrange for my son to see a neuro ophthalmologist, but unfortunately, there are no available appointments until September 2022.
Large, swollen, itchy blotch at the injection site. I hadn?t had any skin reaction with prior doses.
I was starting my nursing clinicals in 1991 and was required to get a tetanus vaccine, this was done by my family physician.  The vaccine was given in my left arm. Within a few hours my left arm, from my elbow up to my shoulder, became extremely sore and swollen.  During the night I could not move my arm away from my body because of intense pain upon moving and had to use my right arm to turn myself over and get out of bed.  The swelling was extreme.  I called my physicians office over the period of a few days only to be told that tetanus vaccines cause soreness and some slight swelling (this was not what I was experiencing).  When I saw my fiance (now husband) he was appalled at the pain I was in and described the swelling as the size of a small nerf football. I just showed up at my physicians office (phone calls were not working), the nurse took one look at my arm  and got my doctor, I was still standing at the desk.  He came out and said "This is NOT what we mean by soreness and swelling."  He then took me back and personally injected my arm in at least 4 areas with cortisone injections. The swelling,  pain, soreness, and difficulty of movement were helped by the injections, but continued on a lesser scale for months.
The response began as moderate-level bicep and armpit pain in the arm in which I had the injection. Pain persisted despite consistent ice therapy and ibuprofen. I could not lift my arm normally (because of severe pain and stiffness) for about two weeks. After two weeks, I could move it more easily with mild pain, but lifting it above shoulder level triggered severe pain. Three weeks after the vaccine, severe itching in my armpits began. The pain spread into my breasts and became severe... the worst breast pain I've ever had in my 48 year old life, which includes painful breasts during menstruation. My primary care physician and gynecologist (who gave me a full breast exam) confirmed that my lymph nodes were swollen. 2 lymph nodes in my upper breasts/armpits remain slightly enlarged. My left bicep still hurts mildly when it's touched and lifted above shoulder level.
Emgality injection (after first dose); Cortisone shot (after first dose); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DRUG INTERACTION (Cortisone shot (after first dose)) and DRUG INTERACTION (Emgality injection (after first dose)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: CORTISONE (Cortisone shot) on 10-Mar-2021. Concurrent medical conditions included Limbic encephalitis, Seizure and Migraine. Concomitant products included GALCANEZUMAB (EMGALITY [GALCANEZUMAB]) for Migraine, CORTISONE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced DRUG INTERACTION (Cortisone shot (after first dose)). On an unknown date, the patient experienced DRUG INTERACTION (Emgality injection (after first dose)). At the time of the report, DRUG INTERACTION (Cortisone shot (after first dose)) and DRUG INTERACTION (Emgality injection (after first dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Additional concomitant medication includes unspecified seizure medication.
headache nagging at the start, then severe and then lessened and lingering nagging headache.
patient details on administration of improperly stored vaccines; This spontaneous report was received from a medical assistant and referred to a 5 year old patient of unknown gender. The patient's concurrent conditions, historical drugs and medical history were not reported. Concomitant therapies included the sterile diluent.  On 28-AUG-2020, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), (lot # S030093 and expiration date 24-MAR-2021; therapy type: recombinant Human albumin (rHA); dose, dose number, vaccination scheme, route of administration, and anatomical site of vaccination were not provided) for prophylaxis (product storage error).   Additionally, it was reported that the suspect vaccines was exposed to a temperature between 6 degrees Fahrenheit (F) to 14 degrees F for a time frame of 50 minutes, as recorded by the digital data logger. There was a previous temperature excursion reported as between 6 degrees F to 14 degrees F (8.47 degrees F) for a time frame of 30 minutes. No further adverse event (AE) information provided.  This is one of multiple reports received from the same reporter.; Sender's Comments:  US-009507513-2009USA000747: US-009507513-2009USA000777: US-009507513-2009USA000699: US-009507513-2009USA000710: US-009507513-2009USA000736: US-009507513-2009USA000749: US-009507513-2009USA000757: US-009507513-2009USA000762: US-009507513-2009USA000976: US-009507513-2009USA001006: US-009507513-2009USA001097: US-009507513-2009USA001099: US-009507513-2009USA001114: US-009507513-2009USA001123: US-009507513-2009USA001135:
Attendee was inadvertently given the adult dose of the Pfizer vaccine at 10:30 a.m.   The attendee did not have any adverse reaction to the vaccine while at the site and had left the site before the error was discovered. The error was not caught until the end of the day, when the RN reconstituter made mention, that he had not opened a vial of Pediatric Vaccine that day. Investigation of how this error occurred and action steps, to prevent this from happening again are underway.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Sep2021 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 72 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single, as dose 2, single and as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history included: "Slightly elevated cholesterol levels" (unspecified if ongoing), notes: Slightly elevated cholesterol levels, controlled by , Atorvastatin. Concomitant medication(s) included: ATORVASTATIN taken for blood cholesterol increased, start date: 02Nov2021. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: indication=Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received Paxlovid as treatment of COVID-19 from 31Aug2022 to 05Sep2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Numbness on both sides of my face, fluttering feeling in brain and tinnitus in both ears
2 incidents with a temporal relationship to rotavirus Rotateq vaccine; at 2 months and 4 months of age.  Patient received 1st dose of Rotateq 11/9/20.   Had blood and mucous in stool 3x on 11/11/20 within 24 hr period; resolved.  Reveived 2nd dose of Rotateq on 1/6/21,  Starting 1/7/21 patient had episodic periods of pain and fussiness with exhaustion.  Would suddenly fall asleep and arouse again as fussy.  Atypical spit up for this patient occurred.  Pt was seen and imaged at urgent care and discharged home.
Area around injection site is once inch in diameter, red, hot, hard, and with six  hives.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), on 31May2022 at 14:30 as dose 4 (booster), single (Lot number: FM0173) at the age of 68 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Trazadone, reaction(s): "allergies". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including received Paxlovid from 19Jul2022 to 24Jul2022.
vesicular rash, which was diagnosed as severe herpes zoster or shingles; The vaccine did not prevent shingles as intended; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age or gender. The patient's medical history, concurrent conditions and concomitant medication use were not provided.   In 2014, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, strength, administration route, anatomical location, lot number and expiration date were not reported) for routine adult health maintenance and for the long-term prevention of shingles at a pharmacy.The reporter stated that the vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later in 2014, the patient was treated in Urgent Care, for the onset of a vesicular rash, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles. The patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages.
fever; lymph node around my ears are still kind of icky/swollen; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on unspecified date in Jan2021 at single dose for covid-19 immunisation.  Medical history included tested positive for the covid virus from 16Dec2020.  The patient's concomitant medications were not reported.  The patient experienced fever and lymph node around ears are still kind of icky and swollen in Jan2021. The outcome of event fever was not recovered; outcome of other event was unknown.  Information on the lot/batch number has been requested.
EE states first noticed itchy rash legs on 3/9/12 several hours after Hepatitis B vaccine. Then developed mild lower lip swelling, vomiting up blood, migraine & rash/hives arms, face & legs. Went to ED where diagnosed with allergic reaction & given IV BENADRYL, IV SOLUMEDROL & po BENADRYL.
29May90 pt vax; devel half-dollar size redness & swelling at inject site.  W/in 15 min redness gone.
Patient moved her arm out of the way during immunization, needle went into arm, did not receive any of the dose as the plunger was not deployed.  Mother will repeat at drs office
Syncope reaction, BP 94/72, P 58, RR 22, 93% 02 Sat water intake encouraged, BP  at 12:45  110/92, P 65 RR 18
Information has been received from a physician concerning a female (age and gender unknown), who, on unspecified dates, was vaccinated with a first and second dose of GARDASIL. Subsequently within twelve hours of receiving both doses the patient fainted. The patient was referred to a cardiologist. The patient sought unspecified medical attention. The patient recovered on an unspecified date. No product quality complaint was involved. Additional information has been requested.
Expired Vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications was reported.  Vial was placed in a refrigerator on 04 Nov 2021.  No Temperature excursion and adverse event was reported.
This spontaneous report as received from a pediatric oncologist via company representative refers to a 13 and a half years old female patient. Medical history and concurrent conditions were not reported. It was reported that the patient had not had medical care in the past 2 years. On 20-OCT-2013, the patient was vaccinated with GARDASIL (dose, route and lot number were not provided). On 20-OCT-2013, the patient had a complete blood count that showed an elevated white blood cell count. On 25-OCT-2013, the blood test was repeated "5 days later" and the white blood cell count was even higher at that time. On 21-DEC-2013, the physician reported that the patient developed fevers, myalgia, bone pain that wakes her from sleep, weight loss and lymphadenopathy a day after (approximately 24 hours) receiving GARDASIL. The patient was also experiencing abdominal pain. The physician states that the patient was admitted to an unspecified hospital. The physician states that although there has not been a final diagnosis, he was "working up" this patient as if she has a severe disseminated cancer. It was reported that physician suspected that the patient had cancer. At the time of the report, the outcome of the events were reported as not recovered and the patient continued to have these symptoms. Upon internal review, Neoplasm malignant was considered to be an other important medical event. The causality was not reported. Additional information has been requested.